These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 6350625

  • 1. Ceftazidime, a new cephalosporin in the treatment of complicated urinary tract infections: a comparative study with tobramycin.
    Frimodt-Møller PC, Madsen PO.
    J Urol; 1983 Oct; 130(4):796-7. PubMed ID: 6350625
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group.
    Sieger B, Berman SJ, Geckler RW, Farkas SA.
    Crit Care Med; 1997 Oct; 25(10):1663-70. PubMed ID: 9377880
    [Abstract] [Full Text] [Related]

  • 6. Ceftazidime vs. tobramycin for serious infections in urological patients.
    Tammela T, Kontturi M, Usenius R, Uusi-Penttilä S, Viitanen J, Jauhiainen K.
    J Hosp Infect; 1990 Apr; 15 Suppl A():69-76. PubMed ID: 1971649
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study.
    Carmeli Y, Armstrong J, Laud PJ, Newell P, Stone G, Wardman A, Gasink LB.
    Lancet Infect Dis; 2016 Jun; 16(6):661-673. PubMed ID: 27107460
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis.
    Permin H, Koch C, Høiby N, Christensen HO, Møller AF, Møller S.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():313-23. PubMed ID: 6352636
    [Abstract] [Full Text] [Related]

  • 13. An open trial of ceftazidime in the treatment of complicated urinary tract infections.
    Matos Ferreira A, Coelho H, de Carvalho MP.
    J Int Med Res; 1984 Jul; 12(6):361-3. PubMed ID: 6394406
    [Abstract] [Full Text] [Related]

  • 14. Complicated urinary tract infections treated with cefuroxime or cefazolin: a comparative study.
    Iversen P, Madsen PO.
    Clin Ther; 1981 Jul; 4(4):302-7. PubMed ID: 7037184
    [Abstract] [Full Text] [Related]

  • 15. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin for the treatment of patients with nosocomial lower respiratory tract infection. Piperacillin/tazobactam Nosocomial Pneumonia Study Group.
    Joshi M, Bernstein J, Solomkin J, Wester BA, Kuye O.
    J Antimicrob Chemother; 1999 Mar; 43(3):389-97. PubMed ID: 10223595
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Randomized comparison of cefepime and ceftazidime for treatment of skin, surgical wound, and complicated urinary tract infections in hospitalized subjects.
    Gentry LO, Rodriguez-Gomez G.
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2371-4. PubMed ID: 1804010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.